Cytori Therapeutics reported $11.4M in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Baxter International BAX:US USD 5.54B 3.32B
Cerus CERS:US USD 73.12M 2.65M
Cytori Therapeutics CYTX:US USD 11.4M 1.72M
Genocea Biosciences GNCA:US USD 12.38M 14.69M
Haemonetics HAE:US USD 729.01M 41.41M
Infinity Pharmaceuticals INFI:US USD -10874000 9.77M
Mirati Therapeutics MRTX:US USD 1.13B 17.05M
Northwest Biotherapeutics NWBO:US USD -95104000 3.44M
Starpharma Holdings Ltd SPL:AU AUD 48.39M 6.69M
Teva Pharmaceutical TEVA:IT USD 8.77B 269M